Overexpression of PTK6 predicts poor prognosis in bladder cancer patients

Protein tyrosine kinase 6 (PTK6) is a non-receptor tyrosine kinase and works as an oncogene in various cancers. Recently, PTK6 has been used as a therapeutic target for breast cancer patients in a clinical study. However, the prognostic value of PTK6 in bladder cancer (BC) remains vague. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xue-lian, Ye, Yun-Lin, Wu, Zhi-Ming, He, Qiu-Ming, Tan, Lei, Xiao, Kang-Hua, Wu, Rui-yan, Yu, Yan, Mai, Jia, Li, Zhi-ling, Peng, Xiao-dan, Huang, Yun, Li, Xuan, Zhang, Hai-liang, Zhu, Xiao-feng, Qin, Zi-Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687160/
https://www.ncbi.nlm.nih.gov/pubmed/29151930
http://dx.doi.org/10.7150/jca.21318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687160/
https://www.ncbi.nlm.nih.gov/pubmed/29151930
http://dx.doi.org/10.7150/jca.21318

Ejemplares similares